Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial.

Karen J Wernli Sarah A Knerr Tengfei Li Kathleen A LeppigKelly EhrlichDavid FarrellHongyuan GaoErin J Aiello Bowles Amanda L Graham George Luta Jinani JayasekeraJeanne S MandelblattMarc D SchwartzSuzanne C O'Neill

Published in: JNCI cancer spectrum (2021)

A web-based, patient-level intervention activated women at elevated 5-year breast cancer risk to engage in clinical discussions about chemoprevention, but uptake remained low.

Keyphrases

breast cancer risk
randomized controlled trial
high resolution
study protocol
case report
clinical trial
phase iii
phase ii
advance care planning
polycystic ovary syndrome
mass spectrometry
insulin resistance
photodynamic therapy
pregnancy outcomes